Moreover, immunohistochemical (IHC) and immunofluorescence (IF) analysis revealed substantial BLT2 expression in tissue samples from lung adenocarcinoma patients with the KrasG12D mutation. Here, LTB4R2 is linked to lung adenocarcinoma.